semaglutide + b12 compounding pharmacy Semaglutide/B12 Injection Home Kit with Telehealth Affordable Compounded Semaglutide – FDA

Zhang XD, Gillespie SK, Borrow JM, Hersey P

Trial design highlights Participants: Adults with BMI 30, or 27 with weight-related conditions Duration: 48 weeks Weekly injection Dose-ranging study (multiple escalating doses) Placebo comparison arm Headline results At the highest dose studied: Mean weight loss approached 24% at 48 weeks Many participants lost 20% Some individuals approached 25% reduction For context: Semaglutide: ~15% Tirzepatide: ~2022% Retatrutide (Phase 2): ~24% These results approach the lower range of bariatric surgical outcomes

[PubMed: 6262917] 452

Long-Term Success and Lifestyle Support Our approach to Medical Weight Loss in Frederick, MD isnt just about shedding pounds its about building healthy habits that last